Recs

2

Does Novartis Pass Buffett's Test?

We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more. Buffett analyzes companies by calculating return on invested capital (ROIC) to help determine whether a company has an economic moat -- the ability to earn returns on its money above that money's cost.

ROIC is perhaps the most important metric in value investing. By determining a company's ROIC, you can see how well it's using the cash you entrust to it and whether it's creating value for you. Simply, it divides a company's operating profit by how much investment it took to get that profit. The formula is

ROIC = Net operating profit after taxes / Invested capital

See more about the nuances of the formula in further detail.

This one-size-fits-all calculation cuts out many of the legal accounting tricks (such as excessive debt) that managers use to boost earnings numbers, and it provides you with an apples-to-apples way to evaluate businesses, even across industries. The higher the ROIC, the more efficient the company uses capital.

Ultimately, we're looking for companies that can invest their money at rates that are higher than the cost of capital, which for most businesses is between 8% and 12%. Ideally, we want to see ROIC above 12%, at a minimum, and a history of increasing returns, or at least steady returns, which indicate some durability to the company's economic moat.

Let's take a look at Novartis (NYSE: NVS  ) and three of its industry peers, to see how efficiently they use cash. Here are the ROIC figures for each company over a few periods.

Company

TTM

1 Year Ago

3 Years Ago

5 Years Ago

Novartis 11.6% 9.9% 12.1% 13.3%
Pfizer (NYSE: PFE  ) 11.8% 8.8% 17.2% 16.7%
GlaxoSmithKline (NYSE: GSK  ) 28% 21.5% 25.3% 34.3%
Merck (NYSE: MRK  ) 13.9% 7.1% 19.7% 19.7%

Source: S&P Capital IQ.

Novartis' returns on invested capital are almost 2 percentage points below what they were five years ago. The other companies have also seen declines in their returns on invested capital over the same time period, though Glaxo managed to keep its numbers at a much higher level than its peers did.

Businesses with consistently high ROIC show that they're efficiently using capital. They also have the ability to treat shareholders well, because they can then use their extra cash to pay out dividends to us, buy back shares, or further invest in their franchise. And healthy and growing dividends are something that Warren Buffett has long loved.

So for more successful investments, dig a little deeper than the earnings headlines to find the company's ROIC. Add these companies to your Watchlist:

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Jim Royal, Ph.D., owns no shares of any company mentioned here. Motley Fool newsletter services have recommended buying shares of Novartis, GlaxoSmithKline, and Pfizer. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1590790, ~/Articles/ArticleHandler.aspx, 5/26/2012 11:43:55 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:01 PM
NVS $51.96 Up +0.23 +0.44%
Novartis CAPS Rating: *****
PFE $22.13 Down -0.01 -0.05%
Pfizer, Inc. CAPS Rating: ****
GSK $44.28 Up +0.04 +0.09%
GlaxoSmithKline CAPS Rating: ****
MRK $37.55 Down -0.05 -0.13%
Merck & Co., Inc. CAPS Rating: ****

Advertisement